Anixa Biosciences, Inc (ANIX) Stock Price

3.49 ▲ +0.31 (+9.75%)
Open: 3.18 Vol: 315.38K Day's range: 3.1401 - 3.50 Aug 17, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ANIX Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 3.48▲ 3.46▲ 3.45▲ 3.26▲ 3.44▲
MA10 3.47▲ 3.43▲ 3.35▲ 3.32▲ 3.26▲
MA20 3.45▲ 3.32▲ 3.29▲ 3.43▲ 3.03▲
MA50 3.37▲ 3.27▲ 3.30▲ 3.10▲ 3.27▲
MA100 3.29▲ 3.32▲ 3.38▲ 2.96▲ 3.12▲
MA200 3.28▲ 3.42▲ 3.37▲ 3.22▲ 3.40▲
  5 mins 30 mins Hourly Daily Weekly
MACD -0.001▼ 0.020▲ 0.034▲ -0.036▼ 0.078▲
RSI 66.453▲ 77.170▲ 73.541▲ 58.154▲ 56.851▲
STOCH 85.648▲ 95.432▲ 95.525▲ 20.488     73.088    
WILL %R 0.000▲ 0.000▲ 0.000▲ -18.733▲ -25.240    
CCI 112.591▲ 102.392▲ 118.019▲ 4.170     65.331    
Latest Filters Detected On ANIX
▲ RSI&VOL $ANIX RSI Cross Up and Volume Set Alert
RSI $ANIX RSI(14) Crossed Above 50 Set Alert
MA $ANIX Price Crossed Above MA(200) Set Alert
MA $ANIX Price Crossed Above MA(26) Set Alert
MA $ANIX Price Crossed Above MA(13) Set Alert
MA $ANIX Price Crossed Above MA(7) Set Alert
Anixa Biosciences, Inc News
Anixa Biosciences Granted First Korean Patent for its Breast Cancer Vaccine, Extending Global Protection Through 2040
Monday, June 29, 2026 05:46 AM
SAN JOSE, Calif., June 29, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...
Anixa Biosciences Announces Presentations of Two Clinical-Stage Immunotherapy Programs at New York Academy of Sciences' Frontiers in Cancer Immunotherapy Symposium
Thursday, June 11, 2026 06:05 AM
SAN JOSE, Calif., June 11, 2026 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...
Anixa Biosciences (ANIX) Price Target Increased by 11.11% to 10.20
Monday, November 17, 2025 03:42 PM
The average one-year price target for Anixa Biosciences (NasdaqCM:ANIX) has been revised to $10.20 / share. This is an increase of 11.11% from the prior estimate of $9.18 dated November 7, 2025. The ...
ANIX historical stock data
date open high low close volume
17/08/26 3.18 3.50 3.1401 3.49 315,383
14/08/26 3.20 3.22 3.10 3.18 107,787
13/08/26 3.24 3.28 3.20 3.20 125,063
12/08/26 3.21 3.33 3.20 3.23 145,304
11/08/26 3.24 3.39 3.22 3.22 135,178
10/08/26 3.32 3.40 3.2206 3.25 256,597
07/08/26 3.43 3.47 3.36 3.42 153,570
06/08/26 3.41 3.53 3.36 3.43 106,452
05/08/26 3.41 3.54 3.37 3.41 181,309
04/08/26 3.42 3.55 3.38 3.41 192,125
Quote Details
52wk Low:2.32
52wk High:5.455
Vol:315.38K
Avg Vol(3m):4.4M
1Y Chng:+16.72%
1M Chng:+17.91%
Add to Watch List
More Information
Index US Composite
Market Cap. 108.87M